A novel TGFβ1 inhibitor delivery system based on fluoro-magnetic nanoparticles (fluoro-MNPs) is developed.
No takes yet. Share an insight, caveat, or question.
Hanafy et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: